Reply to the "comments on the article 'Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations'", by Avogaro (Journal of Diabetes and Its Complications 25 [2011] 352-353)

Journal of Diabetes and its Complications

Volumn 25, Issue 6, 2011, Pages 405-406

  Marfella, Raffaele ^a   Paolisso, Giuseppe ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HEMOGLOBIN A1C; METFORMIN; SITAGLIPTIN; VILDAGLIPTIN;

BLOOD GLUCOSE MONITORING; DISEASE DURATION; DRUG BINDING; DRUG CHOICE; DRUG EFFECT; DRUG EFFICACY; DRUG EXCRETION; DRUG POTENCY; DRUG SELECTIVITY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME;

ADAMANTANE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; FEMALE; HUMANS; MALE; NITRILES; PYRAZINES; PYRROLIDINES; TRIAZOLES;

EID: 82955162961     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2011.05.001     Document Type: Letter

References (8)

1. B. Ahrén Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes Expert Opin Emerging Drugs 13 2011 593 607
2. 1c-independent risk factor for diabetic complications JAMA 295 2006 1707 1708
3. Burkey, B. F. (2006). Vildagliptin displays slow tight-binding to dipeptidyl peptidase (DPP)-4, but not DPP-8 or DPP-9. Poster 0788 presented at EASD.
4. G. Davi, A. Falco, and C. Patrono Lipid peroxidation in diabetes mellitus Antioxid Redox Signal 2005 256 258
5. R. Marfella, M. Barbieri, R. Grella, M.R. Rizzo, G.F. Nicoletti, and G. Paolisso Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations J Diabetes Complications 24 2010 79 83
6. A. Mari, W.M. Sallas, Y.L. He, C. Watson, M. Ligueros-Seylan, and B.E. Dunning Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes J Clin Endocrinol Metab 90 2005 4888 4894 (Pubitemid 41159387)
7. L. Monnier, E. Mas, C. Ginet, F. Michel, L. Villon, and J.P. Cristol Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes JAMA 295 2006 1681 1687
8. S.E. Siegelaar, F. Holleman, J.B.L. Hoekstra, and J.H. DeVries Glucose variability; does it matter? Endocrine Reviews 31 2010 171 182